JCO Article Insights: Xevinapant Plus Chemoradiotherapy in Unresected LA SCCHN
Journal of Clinical Oncology (JCO) Podcast
Release Date: 10/27/2025
Long-Term Remission After Cilta-cel in Patients With RRMM
Journal of Clinical Oncology (JCO) Podcast
Guest Dr. Sundar Jagannath and host Dr. Davide Soldato discuss JCO article "," and the efficacy of CAR-T cell therapy in patients with heavily pretreated RRMM (relapsed/refractory multiple myeloma). TRANSCRIPT Dr. Davide Soldato: Hello and welcome to , the podcast where we sit down with authors from some of the latest articles published in . I am your host, Dr. Davide Soldato, medical oncologist at Ospedale San Martino in Genoa, Italy. Today, we are joined by author, Professor Sundar Jagannath, Professor of Medicine at the Icahn School of Medicine at Mount Sinai and the Tisch Cancer...
info_outline
JCO Article Insights: Xevinapant Plus Chemoradiotherapy in Unresected LA SCCHN
Journal of Clinical Oncology (JCO) Podcast
In this episode of JCO Article Insights, host Dr. Lauren Shih summarizes the article, "" by Bourhis, et al published September 03, 2025 TRANSCRIPT
info_outline
Income Among Adolescents and Young Adults Surviving Cancer
Journal of Clinical Oncology (JCO) Podcast
Host Dr. Shannon Westin and guest Dr. Giancarlo Di Guiseppe discuss the JCO article "" TRANSCRIPT The guest on this podcast episode has no disclosures to declare. Dr. Shannon Westin: Hi everybody and welcome to another episode of , the podcast where we go in depth on manuscripts that are published in the . I'm your host, Dr. Shannon Westin, social media editor of and gynecologic oncologist extraordinaire. I'm so very excited to talk to you today. We're going to speak about "." And I'm joined today by Dr. Giancarlo Di Giuseppe. He has a PhD in epidemiology that he actually just defended...
info_outline
JCO Article Insights: Phase I DLL3/CD3 T-Cell Engager in DLL3-Positive SCLC or NECs
Journal of Clinical Oncology (JCO) Podcast
In this JCO Article Insights episode, Dr. Ece Cal interviews Dr. Martin Wermke, author of the JCO article, "." TRANSCRIPT The disclosures for guests on this podcast can be found in the transcript. Dr. Ece Cali: Welcome to this episode of . This is Dr. Ece Cali, editorial fellow, and today I am joined by Dr. Martin Wermke, Professor for Experimental Cancer Therapy at Dresden University of Technology, to discuss the manuscript “.” Obrixtamig is a bispecific T-cell engager that binds to DLL3 on tumor cells and CD3 on T-cells. This manuscript presents the phase 1A dose escalation results...
info_outline
TTFields in Locally Advanced Pancreatic Adenocarcinoma
Journal of Clinical Oncology (JCO) Podcast
Host Dr. Shannon Westin and guest Dr. Hani Babiker discuss the JCO article "" TRANSCRIPT TTFields in Locally Advanced Pancreatic Adenocarcinoma Dr. Shannon Westin: Hello everyone, and welcome to another episode of , the podcast where we get in depth with manuscripts that have been published in the . I am your host, gynecologic oncologist , social media editor at the JCO, and just excited to be here to learn today about pancreatic cancer. None of our participants have conflicts of interest related to this podcast, and it is my honor to introduce . He is an associate professor of medicine,...
info_outline
JCO at WCLC: Multinational Pivotal Study of Sunvozertinib in Exon20ins NSCLC
Journal of Clinical Oncology (JCO) Podcast
JCO fellow Dr. Ece Cali speaks with JCO Associate Editor Dr. Thomas E. Stinchcombe to discuss the JCO article , that was simultaneously released at the IASLC 2025 World Conference on Lung Cancer. TRANSCRIPT Dr. Ece Cali: Hello, and welcome to our series where we cover some of the top JCO papers published simultaneously with their abstract presentation at this year’s most important oncology meetings. I am your host, Dr. Ece Cali, JCO editorial fellow, and I am joined by Dr. Tom Stinchcombe, JCO associate editor, to discuss the Journal of Clinical Oncology article and 2025 World Conference...
info_outline
Racial and Ethnic Disparities Among Medicare Beneficiaries
Journal of Clinical Oncology (JCO) Podcast
Host Davide Soldato and guest Dr. John K. Lin discuss the JCO article "." TRANSCRIPT The guest on this podcast episode has no disclosures to declare. Dr. Davide Soldato: Hello, and welcome to , the podcast where we sit down with authors of the latest articles published in the . I'm your host, Dr. Davide Soldato, a medical oncologist at Ospedale San Martino in Genoa, Italy. Today, we are joined by Dr. Lin, assistant professor in the Department of Health Services Research at the University of Texas MD Anderson Cancer Center. Dr. Lin and I will be discussing the article titled, "." Thank...
info_outline
JCO Article Insights: Lymph Node Dissection for Lung Cancer
Journal of Clinical Oncology (JCO) Podcast
In this JCO Article Insights episode, Dr. Joseph Matthew interviews authors Dr. Yang Zhang and Dr. Haiquan Chen about their recently published JCO article, "" TRANSCRIPT Joseph Mathew: Welcome to the episode for the August issue of the . This is Joseph Mathew, editorial fellow for JCO, and today, it is my pleasure to have with us Dr. Haiquan Chen and Dr. Yang Zhang, authors of the recently published manuscript, "," which we will be discussing today. Dr. Chen is the Director of the Institute of Thoracic Oncology at Fudan University and the Chief of Thoracic Surgery at Fudan University...
info_outline
JCO Article Insights: IMS-IMWG Consensus on High-Risk Multiple Myeloma
Journal of Clinical Oncology (JCO) Podcast
In this JCO Article Insights episode, Michael Hughes summarizes “International Myeloma Society and International Myeloma Working Group Consensus Recommendations on the Definition of High-Risk Multiple Myeloma" by Avet-Loiseau et al. published on June 09, 2025 along with an interview with author Dr Nikhil C. Munshi, MD. TRANSCRIPT Michael Hughes: Welcome to this episode of . This is Michael Hughes, JCO’s editorial fellow. Today I am interviewing Dr. Nikhil Munshi on the “” by Avet-Loiseau et al. At the time of this recording, our guest has disclosures that will be linked in the...
info_outline
JCO Article Insights: Pooled Taletrectinib Efficacy and Safety
Journal of Clinical Oncology (JCO) Podcast
In this JCO Article Insights episode, host Peter Li summarizes "" by Pérol et al, published April 03, 2025, followed by an interview with first author, Dr Maurice Pérol. TRANSCRIPT The disclosures for guests on this podcast can be found in the show notes. Dr. Peter Li: Welcome to this episode of . I am Dr. Peter Li, JCO’s editorial fellow, and today I am joined by Dr. Maurice Pérol on “,” by Pérol et al. At the time of this recording, our guest has disclosures that will be linked in the transcript. Before we start our interview, I want to give our listeners a quick summary of...
info_outlineIn this episode of JCO Article Insights, host Dr. Lauren Shih summarizes the article, "Xevinapant or Placebo Plus Platinum-Based Chemoradiotherapy in Unresected Locally Advanced Squamous Cell Carcinoma of the Head and Neck (TrilynX): A Randomized, Phase III Study" by Bourhis, et al published September 03, 2025
TRANSCRIPT